Tarsus Pharmaceuticals, Inc.
TARS
DELAYED 1 MONTH
9 insider filings · Latest: Mar 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5 9:03 PM | Seshadri NeervannanChief Operating Officer | Sale | 8,366 | $76.67 | $641.4K | 70,817(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:35 PM | Seshadri NeervannanChief Operating Officer | Option Exercise | 26,287 | — | 15,067(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bryan WahlGeneral Counsel | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Aziz MottiwalaChief Commercial Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Seshadri NeervannanChief Operating Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Dianne C. WhitfieldChief Human Resources Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Elizabeth Yeu LinChief Medical Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Grant/Award | 157,499 | $74.90 | 60,776(D) | View → |